Review



psag1  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc psag1
    (A) Diagram of plasmids expressing CBE (Top) and ABE (Bottom) systems in T. gondii. (B) Expression of base editor proteins in T. gondii at 48 h post‑transfection, as assessed by immunoblotting with profilin as a loading control. (C-J) Quantitative analysis of base editing efficiency at ROP16 and ROP18 loci assessed by Sanger sequencing (C, E, G, I) and amplicon deep sequencing (D, F, H, J) .
    Psag1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 69 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cas9+plasmid/pSAG1%3A%3ACAS9-U6%3A%3AsgUPRT+(Plasmid+%2354467)/pmc13766282-48-17-20
    Average 93 stars, based on 69 article reviews
    psag1 - by Bioz Stars, 2026-11
    93/100 stars

    Images

    1) Product Images from "Base editing-mediated precision genome engineering in Toxoplasma gondii"

    Article Title: Base editing-mediated precision genome engineering in Toxoplasma gondii

    Journal: PLOS Neglected Tropical Diseases

    doi: 10.1371/journal.pntd.0014864

    (A) Diagram of plasmids expressing CBE (Top) and ABE (Bottom) systems in T. gondii. (B) Expression of base editor proteins in T. gondii at 48 h post‑transfection, as assessed by immunoblotting with profilin as a loading control. (C-J) Quantitative analysis of base editing efficiency at ROP16 and ROP18 loci assessed by Sanger sequencing (C, E, G, I) and amplicon deep sequencing (D, F, H, J) .
    Figure Legend Snippet: (A) Diagram of plasmids expressing CBE (Top) and ABE (Bottom) systems in T. gondii. (B) Expression of base editor proteins in T. gondii at 48 h post‑transfection, as assessed by immunoblotting with profilin as a loading control. (C-J) Quantitative analysis of base editing efficiency at ROP16 and ROP18 loci assessed by Sanger sequencing (C, E, G, I) and amplicon deep sequencing (D, F, H, J) .

    Techniques Used: Expressing, Western Blot, Control, Analysis, Base Editing, DNA Sequencing, Amplification, Next-Generation Sequencing

    Related Articles

    other:

    Article Title: Plasmid2MC: efficient cell-free generation of high-purity minicircle DNA for genome editing in mammalian cells.
    Article Snippet: Both the HEK293T and mESC lines were transfected using a Neon Transfection System (Thermo Fisher Scientific) using 10μl tips (Cat#MPK1096K).

    Article Title: Molecular pathology and cystogenic propensity of the ADPKD Taiwan founder variant.
    Article Snippet: MRI imaging was conducted using a Bruker BioSpec (9.4 Tesla).

    Plasmid Preparation:

    Article Title: DROSHA, DICER, and damage-induced long ncRNA control BMI1-dependent transcriptional repression at DNA double-strand break
    Article Snippet: BMI1-GFPAddgene , Addgene , Addgene_128328. .. Cas9 plasmid , Addgene , Addgene_68463. ..

    Article Title: Heterozygous NFKB1 variant causes inflammatory dysregulation shaped by broader genetic context in common variable immunodeficiency
    Article Snippet: iPSCs were validated by via karyotyping, immunofluorescence staining of the human pluripotent stem cell markers TRA-1-60 (Sigma, MAB4360) and TRA-1-81 (Sigma, MAB4381), verification of ability to develop into each of the 3 germ layers (ectoderm, endoderm, mesoderm), and presence of heterozygous NFKB1 variant by sequencing. .. Bacteria containing the Cas9 plasmid (Addgene) was grown in selection media and plasmid DNA extracted using Maxiprep (Qiagen). .. Bacteria containing the Cas9 plasmid (Addgene) was grown in selection media and plasmid DNA extracted using Maxiprep (Qiagen).

    Article Title: Effects of CTCF on the regulatory landscape of the mouse Sox2 locus
    Article Snippet: .. One guide per region was selected (pCM036 for ‘ΔCBS-in-SCR’ and pCM032 for ‘ΔCBS-DS-SCR) and 0.5 million cells were transfected with 1 ug Cas9 plasmid (pX458, Addgene 48138) and 1.5 ug gRNA plasmid using 7.5 ul lipofectamine 2000. ..

    Article Title: Plasmid2MC: efficient cell-free generation of high-purity minicircle DNA for genome editing in mammalian cells
    Article Snippet: At approximately 70% confluency, cells were transfected using Lipofectamine 3000 (Thermo Fisher Scientific) following the manufacturer’s instructions. .. Briefly, 250 ng of Cas9 plasmid (pCAG-1BPNLS-Cas9-1BPNLS, Addgene #87108), 200 ng of gRNA CVs, and 300 ng of HITI mcDNA template were mixed in 50 μ l of Opti-MEM with 1 μ l of 3000 Reagent and 1.5 μ l of Lipofectamine 3000 Reagent per well. .. 48 hours later, cells were harvested by removing the media, washed one time with PBS, and then trypsinized using TrypLE Express (Thermo Fisher Scientific, Cat#12604013) for 3 minutes.

    Article Title: Molecular pathology and cystogenic propensity of the ADPKD Taiwan founder variant
    Article Snippet: Using our previously generated (source Creative Biogene) CRISPR/Cas9-edited HEK293 PKD2 null cell line, we introduced nonsense mutations to both PKD1 alleles to create a PKD1 null :PKD2 null cell line ( ). .. HEK293 PKD2 null cells were electrotransfected with PKD1 sgRNAs ( CACC GCATAGGTGTGGTTGGCAGC and AAAC GCTGCCAACCACACCTATGC) with the All-in-one Cas9 plasmid (Addgene). ..

    Article Title: Enhanced Epigenetic Modulation via mRNA-Encapsulated Lipid Nanoparticles Enables Targeted Anti-inflammatory Control
    Article Snippet: .. Cas9 plasmid was purchased from Addgene (AAV-CMVc-Cas9 #106431). .. The mCherry construct was a premade AAV vector purchased from PackGene Biotech, (ssAAV-CAG-mCherry.WPRE.SV40pA, cat. no. AAV-EA022).

    Bacteria:

    Article Title: Heterozygous NFKB1 variant causes inflammatory dysregulation shaped by broader genetic context in common variable immunodeficiency
    Article Snippet: iPSCs were validated by via karyotyping, immunofluorescence staining of the human pluripotent stem cell markers TRA-1-60 (Sigma, MAB4360) and TRA-1-81 (Sigma, MAB4381), verification of ability to develop into each of the 3 germ layers (ectoderm, endoderm, mesoderm), and presence of heterozygous NFKB1 variant by sequencing. .. Bacteria containing the Cas9 plasmid (Addgene) was grown in selection media and plasmid DNA extracted using Maxiprep (Qiagen). .. Bacteria containing the Cas9 plasmid (Addgene) was grown in selection media and plasmid DNA extracted using Maxiprep (Qiagen).

    Selection:

    Article Title: Heterozygous NFKB1 variant causes inflammatory dysregulation shaped by broader genetic context in common variable immunodeficiency
    Article Snippet: iPSCs were validated by via karyotyping, immunofluorescence staining of the human pluripotent stem cell markers TRA-1-60 (Sigma, MAB4360) and TRA-1-81 (Sigma, MAB4381), verification of ability to develop into each of the 3 germ layers (ectoderm, endoderm, mesoderm), and presence of heterozygous NFKB1 variant by sequencing. .. Bacteria containing the Cas9 plasmid (Addgene) was grown in selection media and plasmid DNA extracted using Maxiprep (Qiagen). .. Bacteria containing the Cas9 plasmid (Addgene) was grown in selection media and plasmid DNA extracted using Maxiprep (Qiagen).

    Transfection:

    Article Title: Effects of CTCF on the regulatory landscape of the mouse Sox2 locus
    Article Snippet: .. One guide per region was selected (pCM036 for ‘ΔCBS-in-SCR’ and pCM032 for ‘ΔCBS-DS-SCR) and 0.5 million cells were transfected with 1 ug Cas9 plasmid (pX458, Addgene 48138) and 1.5 ug gRNA plasmid using 7.5 ul lipofectamine 2000. ..

    Bioprocessing:

    Article Title: Enhanced Epigenetic Modulation via mRNA-Encapsulated Lipid Nanoparticles Enables Targeted Anti-inflammatory Control
    Article Snippet: .. Cas9 plasmid was purchased from Addgene (AAV-CMVc-Cas9 #106431). .. The mCherry construct was a premade AAV vector purchased from PackGene Biotech, (ssAAV-CAG-mCherry.WPRE.SV40pA, cat. no. AAV-EA022).



    Similar Products

    93
    Addgene inc psag1
    (A) Diagram of plasmids expressing CBE (Top) and ABE (Bottom) systems in T. gondii. (B) Expression of base editor proteins in T. gondii at 48 h post‑transfection, as assessed by immunoblotting with profilin as a loading control. (C-J) Quantitative analysis of base editing efficiency at ROP16 and ROP18 loci assessed by Sanger sequencing (C, E, G, I) and amplicon deep sequencing (D, F, H, J) .
    Psag1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cas9+plasmid/pSAG1%3A%3ACAS9-U6%3A%3AsgUPRT+(Plasmid+%2354467)/pmc13766282-48-17-20
    Average 93 stars, based on 1 article reviews
    psag1 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    96
    Addgene inc park313 addgene addgene 200257 aav2 9 rep cap addgene addgene 112865 phelper addgene addgene 112867 ptbg cas9
    (A) Diagram of plasmids expressing CBE (Top) and ABE (Bottom) systems in T. gondii. (B) Expression of base editor proteins in T. gondii at 48 h post‑transfection, as assessed by immunoblotting with profilin as a loading control. (C-J) Quantitative analysis of base editing efficiency at ROP16 and ROP18 loci assessed by Sanger sequencing (C, E, G, I) and amplicon deep sequencing (D, F, H, J) .
    Park313 Addgene Addgene 200257 Aav2 9 Rep Cap Addgene Addgene 112865 Phelper Addgene Addgene 112867 Ptbg Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cas9+plasmid/pAdDeltaF6+(Plasmid+%23112867)/pm42976855-323-294-295
    Average 96 stars, based on 1 article reviews
    park313 addgene addgene 200257 aav2 9 rep cap addgene addgene 112865 phelper addgene addgene 112867 ptbg cas9 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Addgene inc crispr cas9
    (A) Diagram of plasmids expressing CBE (Top) and ABE (Bottom) systems in T. gondii. (B) Expression of base editor proteins in T. gondii at 48 h post‑transfection, as assessed by immunoblotting with profilin as a loading control. (C-J) Quantitative analysis of base editing efficiency at ROP16 and ROP18 loci assessed by Sanger sequencing (C, E, G, I) and amplicon deep sequencing (D, F, H, J) .
    Crispr Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cas9+plasmid/CRISPR-SP-Cas9+reporter+(Plasmid+%2362733)/bio_rxiv__64898__2026__11__04__762546-269-7-27
    Average 96 stars, based on 1 article reviews
    crispr cas9 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    93
    Addgene inc crispr cas9 plasmid pv1382
    (A) Diagram of plasmids expressing CBE (Top) and ABE (Bottom) systems in T. gondii. (B) Expression of base editor proteins in T. gondii at 48 h post‑transfection, as assessed by immunoblotting with profilin as a loading control. (C-J) Quantitative analysis of base editing efficiency at ROP16 and ROP18 loci assessed by Sanger sequencing (C, E, G, I) and amplicon deep sequencing (D, F, H, J) .
    Crispr Cas9 Plasmid Pv1382, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cas9+plasmid/pV1382+(Plasmid+%23111436)/bio_rxiv__64898__2026__11__03__763959-245-1-9
    Average 93 stars, based on 1 article reviews
    crispr cas9 plasmid pv1382 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    96
    Addgene inc lentiv cas9 puro 121
    (A) RT-qPCR quantification of MYC mRNA in cells targeted by sg723 or a non-targeting control (sgCtrl) as in Figure 3B . Data were normalized to sgCtrl. (B) As in A but for MYC protein. Ponceau S was used as loading control. (C) RNA-seq volcano plot showing ASO-induced gene expression change 72 h after ASO treatment ( n = 3). (D) Top three MSigDB hallmark gene sets significantly enriched among genes upregulated or downregulated in ASO treated versus ASO control MDA-MB-231 cells at 72 h. NES: normalized enrichment scores. (E) Scatterplot of NES of MSigDB hallmark gene sets significantly affected (p.adjust < 0.05) by ASO treatment (x-axis) and MYC siRNA knockdown (y-axis) in MDA-MB-231 cells. (F-G) Flow cytometric analysis of apoptosis in MDA-MB-231 cells 72 h after ASO treatment. (H) Western blotting of MYC and LC3 48 h after ASO treatment. M: Marker. (I) Scatterplot of NES of MSigDB hallmark gene sets significant (p.adjust < 0.05) in this study (x-axis) and Lee et al. (y-axis). (J) Western blotting of total and phosphorylated (p-) STING and TBK1 in MDA-MB-231 cells 72 h after ASO treatment. ns: not significant, ****: P < 0.0001.
    Lentiv Cas9 Puro 121, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cas9+plasmid/LentiV_Cas9_puro+(Plasmid+%23108100)/pmc13739239-442-11-13
    Average 96 stars, based on 1 article reviews
    lentiv cas9 puro 121 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Addgene inc crispr cas9 plasmid
    (A) RT-qPCR quantification of MYC mRNA in cells targeted by sg723 or a non-targeting control (sgCtrl) as in Figure 3B . Data were normalized to sgCtrl. (B) As in A but for MYC protein. Ponceau S was used as loading control. (C) RNA-seq volcano plot showing ASO-induced gene expression change 72 h after ASO treatment ( n = 3). (D) Top three MSigDB hallmark gene sets significantly enriched among genes upregulated or downregulated in ASO treated versus ASO control MDA-MB-231 cells at 72 h. NES: normalized enrichment scores. (E) Scatterplot of NES of MSigDB hallmark gene sets significantly affected (p.adjust < 0.05) by ASO treatment (x-axis) and MYC siRNA knockdown (y-axis) in MDA-MB-231 cells. (F-G) Flow cytometric analysis of apoptosis in MDA-MB-231 cells 72 h after ASO treatment. (H) Western blotting of MYC and LC3 48 h after ASO treatment. M: Marker. (I) Scatterplot of NES of MSigDB hallmark gene sets significant (p.adjust < 0.05) in this study (x-axis) and Lee et al. (y-axis). (J) Western blotting of total and phosphorylated (p-) STING and TBK1 in MDA-MB-231 cells 72 h after ASO treatment. ns: not significant, ****: P < 0.0001.
    Crispr Cas9 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cas9+plasmid/CRISPR-SP-Cas9+reporter+(Plasmid+%2362733)/pm42976007-252-5-19
    Average 96 stars, based on 1 article reviews
    crispr cas9 plasmid - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Addgene inc cas9 sgrna co expression plasmids
    (A) RT-qPCR quantification of MYC mRNA in cells targeted by sg723 or a non-targeting control (sgCtrl) as in Figure 3B . Data were normalized to sgCtrl. (B) As in A but for MYC protein. Ponceau S was used as loading control. (C) RNA-seq volcano plot showing ASO-induced gene expression change 72 h after ASO treatment ( n = 3). (D) Top three MSigDB hallmark gene sets significantly enriched among genes upregulated or downregulated in ASO treated versus ASO control MDA-MB-231 cells at 72 h. NES: normalized enrichment scores. (E) Scatterplot of NES of MSigDB hallmark gene sets significantly affected (p.adjust < 0.05) by ASO treatment (x-axis) and MYC siRNA knockdown (y-axis) in MDA-MB-231 cells. (F-G) Flow cytometric analysis of apoptosis in MDA-MB-231 cells 72 h after ASO treatment. (H) Western blotting of MYC and LC3 48 h after ASO treatment. M: Marker. (I) Scatterplot of NES of MSigDB hallmark gene sets significant (p.adjust < 0.05) in this study (x-axis) and Lee et al. (y-axis). (J) Western blotting of total and phosphorylated (p-) STING and TBK1 in MDA-MB-231 cells 72 h after ASO treatment. ns: not significant, ****: P < 0.0001.
    Cas9 Sgrna Co Expression Plasmids, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cas9+plasmid/pSpCas9(BB)-2A-Puro+(PX459)+V2%2E0+(Plasmid+%2362988)/bio_rxiv__64898__2026__10__31__763349-157-21-25
    Average 96 stars, based on 1 article reviews
    cas9 sgrna co expression plasmids - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    93
    Addgene inc pich47742 35spro cas9
    (A) RT-qPCR quantification of MYC mRNA in cells targeted by sg723 or a non-targeting control (sgCtrl) as in Figure 3B . Data were normalized to sgCtrl. (B) As in A but for MYC protein. Ponceau S was used as loading control. (C) RNA-seq volcano plot showing ASO-induced gene expression change 72 h after ASO treatment ( n = 3). (D) Top three MSigDB hallmark gene sets significantly enriched among genes upregulated or downregulated in ASO treated versus ASO control MDA-MB-231 cells at 72 h. NES: normalized enrichment scores. (E) Scatterplot of NES of MSigDB hallmark gene sets significantly affected (p.adjust < 0.05) by ASO treatment (x-axis) and MYC siRNA knockdown (y-axis) in MDA-MB-231 cells. (F-G) Flow cytometric analysis of apoptosis in MDA-MB-231 cells 72 h after ASO treatment. (H) Western blotting of MYC and LC3 48 h after ASO treatment. M: Marker. (I) Scatterplot of NES of MSigDB hallmark gene sets significant (p.adjust < 0.05) in this study (x-axis) and Lee et al. (y-axis). (J) Western blotting of total and phosphorylated (p-) STING and TBK1 in MDA-MB-231 cells 72 h after ASO treatment. ns: not significant, ****: P < 0.0001.
    Pich47742 35spro Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cas9+plasmid/pICH47742%3A%3A2x35S-5%E2%80%99UTR-hCas9(STOP)-NOST+(Plasmid+%2349771)/pm42971919-65-10-12
    Average 93 stars, based on 1 article reviews
    pich47742 35spro cas9 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    96
    Addgene inc lentiviral crispri plasmid encoding nuclease dead cas9
    (A) RT-qPCR quantification of MYC mRNA in cells targeted by sg723 or a non-targeting control (sgCtrl) as in Figure 3B . Data were normalized to sgCtrl. (B) As in A but for MYC protein. Ponceau S was used as loading control. (C) RNA-seq volcano plot showing ASO-induced gene expression change 72 h after ASO treatment ( n = 3). (D) Top three MSigDB hallmark gene sets significantly enriched among genes upregulated or downregulated in ASO treated versus ASO control MDA-MB-231 cells at 72 h. NES: normalized enrichment scores. (E) Scatterplot of NES of MSigDB hallmark gene sets significantly affected (p.adjust < 0.05) by ASO treatment (x-axis) and MYC siRNA knockdown (y-axis) in MDA-MB-231 cells. (F-G) Flow cytometric analysis of apoptosis in MDA-MB-231 cells 72 h after ASO treatment. (H) Western blotting of MYC and LC3 48 h after ASO treatment. M: Marker. (I) Scatterplot of NES of MSigDB hallmark gene sets significant (p.adjust < 0.05) in this study (x-axis) and Lee et al. (y-axis). (J) Western blotting of total and phosphorylated (p-) STING and TBK1 in MDA-MB-231 cells 72 h after ASO treatment. ns: not significant, ****: P < 0.0001.
    Lentiviral Crispri Plasmid Encoding Nuclease Dead Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cas9+plasmid/pLV+hU6-sgRNA+hUbC-dCas9-KRAB-T2a-Puro+(Plasmid+%2371236)/pm42963426-436-4-30
    Average 96 stars, based on 1 article reviews
    lentiviral crispri plasmid encoding nuclease dead cas9 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Addgene inc spcas9 ec plasmid
    (A) RT-qPCR quantification of MYC mRNA in cells targeted by sg723 or a non-targeting control (sgCtrl) as in Figure 3B . Data were normalized to sgCtrl. (B) As in A but for MYC protein. Ponceau S was used as loading control. (C) RNA-seq volcano plot showing ASO-induced gene expression change 72 h after ASO treatment ( n = 3). (D) Top three MSigDB hallmark gene sets significantly enriched among genes upregulated or downregulated in ASO treated versus ASO control MDA-MB-231 cells at 72 h. NES: normalized enrichment scores. (E) Scatterplot of NES of MSigDB hallmark gene sets significantly affected (p.adjust < 0.05) by ASO treatment (x-axis) and MYC siRNA knockdown (y-axis) in MDA-MB-231 cells. (F-G) Flow cytometric analysis of apoptosis in MDA-MB-231 cells 72 h after ASO treatment. (H) Western blotting of MYC and LC3 48 h after ASO treatment. M: Marker. (I) Scatterplot of NES of MSigDB hallmark gene sets significant (p.adjust < 0.05) in this study (x-axis) and Lee et al. (y-axis). (J) Western blotting of total and phosphorylated (p-) STING and TBK1 in MDA-MB-231 cells 72 h after ASO treatment. ns: not significant, ****: P < 0.0001.
    Spcas9 Ec Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cas9+plasmid/SP-Cas9+(Plasmid+%2362731)/bio_rxiv__64898__2026__10__28__762406-195-26-28
    Average 96 stars, based on 1 article reviews
    spcas9 ec plasmid - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    (A) Diagram of plasmids expressing CBE (Top) and ABE (Bottom) systems in T. gondii. (B) Expression of base editor proteins in T. gondii at 48 h post‑transfection, as assessed by immunoblotting with profilin as a loading control. (C-J) Quantitative analysis of base editing efficiency at ROP16 and ROP18 loci assessed by Sanger sequencing (C, E, G, I) and amplicon deep sequencing (D, F, H, J) .

    Journal: PLOS Neglected Tropical Diseases

    Article Title: Base editing-mediated precision genome engineering in Toxoplasma gondii

    doi: 10.1371/journal.pntd.0014864

    Figure Lengend Snippet: (A) Diagram of plasmids expressing CBE (Top) and ABE (Bottom) systems in T. gondii. (B) Expression of base editor proteins in T. gondii at 48 h post‑transfection, as assessed by immunoblotting with profilin as a loading control. (C-J) Quantitative analysis of base editing efficiency at ROP16 and ROP18 loci assessed by Sanger sequencing (C, E, G, I) and amplicon deep sequencing (D, F, H, J) .

    Article Snippet: For the ROP18 -KO targeting assay, CRISPR-CAS9 plasmid targeting ROP18 (pSAG1::CAS9-U6::sg ROP18 ) was engineered from the pSAG1::CAS9-U6::sg UPRT backbone (Addgene #54467) using the Q5 Site-Directed Mutagenesis Kit (New England Biolabs, E0554) to substitute the UPRT -targeting gRNA with ROP18 -specific sgRNAs.

    Techniques: Expressing, Western Blot, Control, Analysis, Base Editing, DNA Sequencing, Amplification, Next-Generation Sequencing

    (A) RT-qPCR quantification of MYC mRNA in cells targeted by sg723 or a non-targeting control (sgCtrl) as in Figure 3B . Data were normalized to sgCtrl. (B) As in A but for MYC protein. Ponceau S was used as loading control. (C) RNA-seq volcano plot showing ASO-induced gene expression change 72 h after ASO treatment ( n = 3). (D) Top three MSigDB hallmark gene sets significantly enriched among genes upregulated or downregulated in ASO treated versus ASO control MDA-MB-231 cells at 72 h. NES: normalized enrichment scores. (E) Scatterplot of NES of MSigDB hallmark gene sets significantly affected (p.adjust < 0.05) by ASO treatment (x-axis) and MYC siRNA knockdown (y-axis) in MDA-MB-231 cells. (F-G) Flow cytometric analysis of apoptosis in MDA-MB-231 cells 72 h after ASO treatment. (H) Western blotting of MYC and LC3 48 h after ASO treatment. M: Marker. (I) Scatterplot of NES of MSigDB hallmark gene sets significant (p.adjust < 0.05) in this study (x-axis) and Lee et al. (y-axis). (J) Western blotting of total and phosphorylated (p-) STING and TBK1 in MDA-MB-231 cells 72 h after ASO treatment. ns: not significant, ****: P < 0.0001.

    Journal: Cell

    Article Title: CRISPR mutagenesis of the MYC locus reveals a druggable ultraconserved RNA element

    doi: 10.1016/j.cell.2026.10.002

    Figure Lengend Snippet: (A) RT-qPCR quantification of MYC mRNA in cells targeted by sg723 or a non-targeting control (sgCtrl) as in Figure 3B . Data were normalized to sgCtrl. (B) As in A but for MYC protein. Ponceau S was used as loading control. (C) RNA-seq volcano plot showing ASO-induced gene expression change 72 h after ASO treatment ( n = 3). (D) Top three MSigDB hallmark gene sets significantly enriched among genes upregulated or downregulated in ASO treated versus ASO control MDA-MB-231 cells at 72 h. NES: normalized enrichment scores. (E) Scatterplot of NES of MSigDB hallmark gene sets significantly affected (p.adjust < 0.05) by ASO treatment (x-axis) and MYC siRNA knockdown (y-axis) in MDA-MB-231 cells. (F-G) Flow cytometric analysis of apoptosis in MDA-MB-231 cells 72 h after ASO treatment. (H) Western blotting of MYC and LC3 48 h after ASO treatment. M: Marker. (I) Scatterplot of NES of MSigDB hallmark gene sets significant (p.adjust < 0.05) in this study (x-axis) and Lee et al. (y-axis). (J) Western blotting of total and phosphorylated (p-) STING and TBK1 in MDA-MB-231 cells 72 h after ASO treatment. ns: not significant, ****: P < 0.0001.

    Article Snippet: First, the LentiV-HF1-SpRY-ABE8e_puro plasmid was constructed by assembling fragments derived from LentiV_Cas9_puro 121 (Addgene, 108100) and pCMV-SpRY-HF1-ABE8e 122 (Addgene, 185670) using the Gibson Assembly Master Mix (NEB, E2611S) according to the manufacturer’s instructions.

    Techniques: Activity Assay, Quantitative RT-PCR, Control, RNA Sequencing, Gene Expression, Knockdown, Analysis, Western Blot, Marker